In the liver there is a fine balance between immune surveillance of blood-borne infections and regulation of immunopathology. A new study identifies a role for granulocytic myeloid-derived suppressor cells in limiting T cell–mediated immunopathology in hepatitis B virus infection.
References
Jenne, C.N. & Kubes, P. Nat. Immunol. 14, 996–1006 (2013).
Barnaba, V., Paroli, M. & Piconese, S. Front. Immunol. 3, 18 (2012).
Pallett, L.J. et al. Nat. Med. 21, 591–600 (2015).
Wherry, E.J. Nat. Immunol. 12, 492–499 (2011).
Solito, S. et al. Blood 118, 2254–2265 (2011).
Rodriguez, P.C. et al. Cancer Res. 69, 1553–1560 (2009).
Sato, S. et al. Immunity 42, 123–132 (2015).
Chiu, Y.S., Wei, C.C., Lin, Y.J., Hsu, Y.H. & Chang, M.S. Hepatology 60, 1003–1014 (2014).
Liu, G. et al. J. Immunol. 192, 3068–3079 (2014).
Noman, M.Z. et al. J. Exp. Med. 211, 781–790 (2014).
Franceschini, D. et al. J. Clin. Invest. 119, 551–564 (2009).
Piconese, S. et al. Hepatology 60, 1494–1507 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Piconese, S., Barnaba, V. Regulation of immunopathology in hepatitis B virus infection. Nat Med 21, 548–549 (2015). https://doi.org/10.1038/nm.3873
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3873
- Springer Nature America, Inc.